Will Downsized Korean Biopharma Fund Launch Successfully This Time?
Weak But Improving Sentiment
Given that previously announced similar programs failed to attract strong investor interest, South Korea is set to create a new biopharma fund but of a smaller target size and lower qualifying thresholds as it continues to support industry development.
